Phase 4
Completed N=218
Effectiveness of Varenicline: Testing Individual Differences
Smoking Addiction
Source: ClinicalTrials.gov NCT01228175 ↗
Enrolled (actual)
218
Serious AEs
0.0%
Results posted
Nov 2016
Primary outcomePrimary: Cigarettes Per Smoking Day — 4.9256; 8.4989 Cigarettes per smoking day
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
The study will evaluate the effectiveness of smoking cessation using Varenicline versus placebo. Effectiveness will be measured by the average number of cigarettes smoked per smoking day for up to 36 weeks.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cigarettes Per Smoking Day |
4.9256; 8.4989 | — |
Eligibility Criteria
Inclusion Criteria
- 18 yrs to 55 yrs
- smoker
Exclusion Criteria
- Medical Contraindications
Data sourced from ClinicalTrials.gov (NCT01228175). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.